Swedbank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6M Sell
61,894
-321
-0.5% -$96.8K 0.02% 414
2026
Q1
$20.6M Buy
62,215
+273
+0.4% +$92.9K 0.02% 368
2025
Q4
$24.6M Sell
61,942
-1,636
-3% -$724K 0.02% 351
2025
Q3
$29M Sell
63,578
-737
-1% -$300K 0.03% 313
2025
Q2
$21M Buy
64,315
+4,322
+7% +$1.2M 0.02% 357
2025
Q1
$16.2M Buy
59,993
+4,461
+8% +$1.15M 0.02% 390
2024
Q4
$13.1M Buy
55,532
+1,803
+3% +$474K 0.02% 425
2024
Q3
$14.8M Buy
53,729
+33,090
+160% +$8.62M 0.02% 402
2024
Q2
$5.02M Hold
20,639
0.01% 534
2024
Q1
$3.08M Sell
20,639
-200,000
-91% -$33.4M 0.03% 439
2023
Q4
$42.2M Hold
220,639
0.07% 203
2023
Q3
$39.1M Sell
220,639
-113,303
-34% -$21.6M 0.07% 198
2023
Q2
$63.4M Hold
333,942
0.11% 159
2023
Q1
$66.9M Sell
333,942
-92,711
-22% -$19.5M 0.13% 144
2022
Q4
$101M Buy
426,653
+10,593
+3% +$2.26M 0.22% 98
2022
Q3
$83.3M Sell
416,060
-23,152
-5% -$4.42M 0.2% 103
2022
Q2
$64.1M Buy
439,212
+856
+0.2% +$121K 0.14% 139
2022
Q1
$71.6M Buy
438,356
+1,791
+0.4% +$273K 0.13% 144
2021
Q4
$74.7M Buy
436,565
+67
+0% +$12.5K 0.13% 149
2021
Q3
$82.4M Buy
436,498
+90,986
+26% +$17.1M 0.15% 129
2021
Q2
$58.6M Buy
345,512
+5,193
+2% +$761K 0.11% 174
2021
Q1
$48M Buy
+340,319
New +$51.2M 0.1% 190

Other funds holding ALNY